Following specialists treat Hodgkin Disease. Help us improve our data based on your experience.
Specialty scores for Hodgkin Disease
Source: In partnership with Genetic and Rare Diseases Information Center, funded by the National Center for Advancing Translational Sciences, and the National Human Genome Research Institute https://rarediseases.info.nih.gov/gard.
Abnormality of immune system physiology
Abnormality of temperature regulation
Bone marrow hypocellularity
Autosomal recessive inheritance
Impaired lymphocyte transformation with phytohemagglutinin
Polyclonal elevation of IgM
Trade Name: Adcetris
Indication: The treatment of patients with Hodgkin lymphoma after failure of autologous stem cell transplant (ASCT) or after failure of at least two prior multi-agent chemotherapy regimens in patients who are not ASCT candidates.
Trade Name: Opdivo
Indication: The treatment of Classical Hodgkin lymphoma that has relapsed or progressed after autologous hematopoietic stem cell transplantation (HSCT) and post-transplantation brentuximab vedotin.